EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

γδ T Cells: Game Changers in Immune Cell Therapy for Cancer

Nabil Subhi-Issa, Daniel Tovar Manzano iD, Alejandro Pereiro Rodriguez, Silvia Sanchez Ramon iD, Pedro Perez Segura, Alberto Ocaña iD

Cancers · 21.03.2025 · 17 (7) · 1063

DOI: 10.3390/cancers17071063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.03.2025. Verfasst von Nabil Subhi-Issa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gamma delta (γδ) T cells are a unique subset of T lymphocytes with distinctive features that make them highly promising candidates for cancer therapy. Their MHC-independent recognition of tumor antigens, ability to mediate direct cytotoxicity, and role in modulating the tumor microenvironment position them as versatile agents in cancer immunotherapy. This review integrates and synthesizes the existing data on γδ T cells, with an emphasis on the development and optimization of in vitro expansion protocols. Critical aspects are detailed such as activation strategies, co-culture systems, cytokine use, and other parameters to ensure robust cell proliferation and functionality, which may be valuable for those developing or optimizing clinical practices. Finally, we discuss current advancements in γδ T cell research, clinical experience, and highlight areas needing further exploration. Considering these data, we hypothesize and propose potential new applications such as engineering γδ T cells for enhanced resistance to immune checkpoint pathways or for localized cytokine delivery within the tumor microenvironment, which could broaden their therapeutic impact in the treatment of cancer and beyond.

Schlagwörter

Stichwörter der Autor:innen

adoptive cell therapycancer immunotherapycellular expansion protocolstumor microenvironmentγδ T cells

Autor:innen und Institutionen

  • Department of Immunology, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
  • Department of Immunology, Ophthalmology, and ORL, School of Medicine, Complutense University, 28040 Madrid, Spain.
  • Department of Oncology, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.

ORCID-Profile: Daniel Tovar Manzano, Silvia Sanchez Ramon, Alberto Ocaña

Zitieren

APA

Subhi-Issa, N., Tovar Manzano, D., Pereiro Rodriguez, A., Sanchez Ramon, S., Perez Segura, P., & Ocaña, A. (2025). γδ T Cells: Game Changers in Immune Cell Therapy for Cancer. Cancers, 17(7), 1063. https://doi.org/10.3390/cancers17071063

Vancouver

Subhi-Issa N, Tovar Manzano D, Pereiro Rodriguez A, Sanchez Ramon S, Perez Segura P, Ocaña A. γδ T Cells: Game Changers in Immune Cell Therapy for Cancer. Cancers. 2025;17(7):1063. doi:10.3390/cancers17071063

BibTeX
@article{SubhiIssa2025,
  author = {Subhi-Issa, Nabil and Tovar Manzano, Daniel and Pereiro Rodriguez, Alejandro and Sanchez Ramon, Silvia and Perez Segura, Pedro and Ocaña, Alberto},
  title = {γδ T Cells: Game Changers in Immune Cell Therapy for Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1063},
  doi = {10.3390/cancers17071063}
}
Kostenlos starten →